Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Shares Issued (2021 - 2023)

Historic Shares Issued for ADC Therapeutics (ADCT) over the last 3 years, with Q4 2023 value amounting to -$1000.0.

  • ADC Therapeutics' Shares Issued fell 10001.63% to -$1000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $773000.0, marking a year-over-year decrease of 8738.99%. This contributed to the annual value of $60.5 million for FY2024, which is 772742.56% up from last year.
  • According to the latest figures from Q4 2023, ADC Therapeutics' Shares Issued is -$1000.0, which was down 10001.63% from $349000.0 recorded in Q3 2023.
  • ADC Therapeutics' 5-year Shares Issued high stood at $6.1 million for Q4 2022, and its period low was -$1000.0 during Q4 2023.
  • Over the past 3 years, ADC Therapeutics' median Shares Issued value was $282.0 (recorded in 2021), while the average stood at $767086.4.
  • In the last 5 years, ADC Therapeutics' Shares Issued soared by 233723129.77% in 2022 and then crashed by 10001.63% in 2023.
  • ADC Therapeutics' Shares Issued (Quarter) stood at $262.0 in 2021, then soared by 2337231.3% to $6.1 million in 2022, then crashed by 100.02% to -$1000.0 in 2023.
  • Its last three reported values are -$1000.0 in Q4 2023, $349000.0 for Q3 2023, and $425000.0 during Q1 2023.